Fig. 1.
Reported demographic characteristics of patients that received hepatitis B vaccine doses adminstered through the pilot project, 2012–2015.1–3.
Footnotes:
1Data tracking issues (e.g., coding errors in distinguishing doses funded by the pilot and doses funded by other sources) resulted in some- over and under-counting of doses among awardees.
2Florida’s data were not included in figure, as their age groups and race/ethnicity were collected using different categories from other awardees. Florida reported vaccination of persons in the following age groups: 16–18 years (n = 14), 19 years (n = 42), 20–49 years (n = 7082), and 50–64 years (n = 3468). Florida reported vaccination among the following racial and ethnic groups: white (n = 8410), black (n = 3770), American Indian/Alaskan (n = 68), and Asian/Pacific Islander (n = 185), and Hispanic (n = 3,407), Non-Hispanic (n = 8701), Haitian (n = 307), and no answer (n = 18)].
3Individuals could report more than one race/ethnicity.